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Introduction: Mesenchymal stem cells (MSCs) have potent stabilising effects on vascular endothelium injury, inhibiting
endothelial permeability in lung injury via paracrine hepatocyte growth factor (HGF). Recently, it has been indicated that
MSCs secrete more factors by MSC-endothelial cell (MSC-EC) interactions. We hypothesised that MSC-EC interactions
restore endothelial permeability induced by lipopolysaccharide (LPS) via paracrine HGF.
Methods: We investigated the endothelial permeability induced by LPS under two co-culture conditions. Human
pulmonary microvascular endothelial cells (HPMECs) were added into the upper chambers of cell-culture inserts,
while two different co-culture conditions were used in the lower side of the transwells, as follows: (1) MSC-EC
interaction group: MSCs and HPMECs contact co-culture; (2) MSC group: MSCs only. The endothelial paracellular
and transcellular permeabilities in the upper side of transwells were detected. Then the concentration of HGF was
measured in the culture medium by using an enzyme-linked immunosorbent assay kit, followed by neutralisation
of HGF with anti-HGF antibody in the co-culture medium. In addition, adherens junction and cytoskeleton protein
expressions were measured by Western blot and immunofluorescence. HPMEC proliferation was analysed by
bromodeoxyuridine incorporation assay.
Results: The paracellular permeability significantly increased after LPS stimulation in a dose-dependent and
time-dependent manner. Meanwhile, MSC-EC interaction more significantly decreased endothelial paracellular
and transcellular permeability induced by LPS. Moreover, HGF levels in the MSC-EC interaction group were much
higher than those of the MSC group. However, neutralising HGF with anti-HGF antibody inhibited the role of
MSC-EC interaction in improving endothelial permeability. Compared with the MSC group, MSC-EC interaction
increased vascular endothelial (VE)-cadherin and occludin protein expression, reduced caveolin-1 protein expression in
HPMECs, and restored remodelling of F-actin and junctional localisation of VE-cadherin. Furthermore, the proliferation
ratio in the MSC-EC interaction group was higher than that of the MSC group. However, the effects of MSCs were
significantly blocked by anti-HGF antibody.
Conclusions: These data suggested that MSC-EC interaction decreased endothelial permeability induced by LPS, which
was attributed mainly to HGF secreted by MSCs. The main mechanisms by which HGF restored the integrity of
endothelial monolayers were remodelling of endothelial intercellular junctions, decreasing caveolin-1 protein
expression, and inducing proliferation in HPMECs.* Correspondence: yiyiyang2004@gmail.com
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Acute lung injury (ALI) involves a disruption of the
alveolar-capillary membranes, with an excessive and un-
controlled inflammatory response leading to pulmonary
oedema with serum proteins and oedema fluid [1]. ALI
pathogenesis is still only partly understood; however,
pulmonary endothelial cell (EC) dysfunction is a key
component of ALI pathogenesis because EC play a
major role by changing their barrier permeability [2]. As
ALI is characterised by endothelial hyperpermeability, sta-
bilising EC barrier function is critical for treating ALI [3].
A growing number of studies have provided convin-
cing data on the beneficial effects of mesenchymal stem
cells (MSCs) in treating ALI induced by endotoxin [4-6].
Studies have shown that MSCs have potent stabilising
effects on vascular endothelium injury by inhibiting
endothelial permeability after injury via modulation of
adherens junction (AJ) proteins [7]. However, the de-
tailed pathogenesis of MSCs in improving endothelial in-
jury is still unclear. Much of the current research has
suggested that multipotent differentiation of MSCs con-
tributes minimally to the beneficial effects but that para-
crine activity plays a predominant role [8,9]. Thus,
MSCs improve endothelial injury mainly through a para-
crine mechanism.
Hepatocyte growth factor (HGF) is a multifunctional,
mesenchyme-derived pleiotropic factor secreted by
MSCs [10-12]. HGF appears in lung circulation under
pathological conditions, such as ALI, and exhibits sus-
tained barrier-protective effects on human pulmonary
ECs [13]. MSCs secrete a small amount of HGF under
normal conditions; however, high HGF levels have been
detected in MSC medium under pathological conditions
[14-16]. Recently, it has been found that MSCs secrete
more factors following MSC-EC interactions [17].
Therefore, HGF resulting from MSC-EC interactions
could be the key factor from MSCs that improve endo-
thelial permeability.
The aim of the present study was to illuminate the ef-
fect and mechanism of MSC-EC interaction in the integ-
rity of an EC monolayer induced by lipopolysaccharide
(LPS). We investigated the effect of MSC-EC interaction
on endothelial paracellular and transcellular permeability
by performing two in vitro co-culture experiments and
then explored the role and mechanism of HGF in regu-
lating the integrity of a human pulmonary microvascular
EC (HPMEC) monolayer by neutralising HGF with HGF
antibody.
Methods
Human mesenchymal stem cell culture
Human mesenchymal stem cells (hMSCs) and HPMECs
were used in the present study. hMSCs were purchased
from Cyagen Biosciences Inc. (Guangzhou, China). Anadditional statement of ethics for hMSC use shows this
in more detail (Additional file 1). The cells were identi-
fied by detecting cell surface phenotypes. Fluorescein-
conjugated monoclonal antibodies, including CD29,
CD34, CD44, CD105, and CD45, and the respective isotype
controls were purchased from Miltenyi Biotec (Bergisch
Gladbach, Germany). Flow cytometry was performed with
fluorescence-activated cell sorting analysis (Figure 1). The
multipotent potential for differentiation along adipogenic,
osteogenic, and chondrogenic lineages was determined by
staining with Oil Red O, Alizarin red, or Toluidine blue, re-
spectively, followed by culture in adipogenic, osteogenic, or
chondrogenic differentiation media (Cyagen Biosciences
Inc.) for 2 to 3 weeks (Figure 2), thus verifying their iden-
tity as hMSCs. hMSCs were cultured in MSC growth
medium (Cyagen Biosciences Inc.). All cells were cultured
in a humidified 5% CO2 incubator at 37°C. The culture
media were changed every 3 days, and the cells were used
at passages 3 to 7 for all experiments.
Human pulmonary microvascular endothelial cell culture
First-passage HPMECs were obtained from ScienCell
Research Laboratories (Carlsbad, CA, USA). An add-
itional ethical approval for HPMEC use shows this in
more detail (Additional file 2). HPMECs were routinely
characterised by the supplier. HPMECs were added into
the upper chambers of 0.4-μm cell-culture inserts at a
density of 50,000 cells per insert well and cultured in
EGM-2 (endothelial growth media-2) (ScienCell Research
Laboratories). The culture media were changed every
3 days, and the cells were used at passages 3 to 7 for all
experiments.
Mesenchymal stem cell-endothelial cell interaction
through transwell inserts
HPMECs were added to the upper chambers of 0.4-μm
cell-culture inserts (0.4-μm pore size polyester mem-
brane from Corning Inc., Corning, NY, USA) at a density
of 50,000 cells per insert well. Different co-culture condi-
tions were used in the lower side of transwells: (1) MSC-EC
interaction group: hMSCs mixed with HPMECs were plated
in the lower chambers at a density of 100,000 cells/cm2;
(2) MSC group: Only MSCs were plated in the lower
chambers. After growing to confluence, the medium
was changed with Dulbecco’s modified Eagle’s medium/
F12 supplemented with 10% fetal bovine serum (Wisent
Inc., Nanjing, China) containing 0, 1, 10, 100, 1,000, and
10,000 ng/mL LPS (Sigma-Aldrich, St. Louis, MO, USA)
and cultured for 0, 1, 2, 6, 12, and 24 hours, respectively.
Human pulmonary microvascular endothelial cell
permeability examination
HPMECs were seeded at 50,000 cells per insert well and
cultured for 1 to 3 days to allow the growth of a
Figure 1 Flow cytometry identification of human mesenchymal stem cells (hMSCs). Cell surface markers of hMSCs, including CD34, CD44,
CD105, CD29, and CD45, were analysed with flow cytometry. Red lines represent the isotype controls. The supplier guarantees that there is no
ethical issue in using the hMSCs for experiments. FSC-H, forward scatter height; SSC-H, side scatter height.
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100 ng/mL LPS for 6 hours before testing permeability.
Paracellular permeability was tested by adding 10 μL of
10 mg/mL fluorescein isothiocyanate (FITC)-Dextran
(Sigma-Aldrich) to the upper chamber, as previously de-
scribed [18]. The FITC component from samples was
obtained 40 minutes after the addition of FITC-Dextran.
Medium (100 μL) was withdrawn from the lower well
and upper well, respectively. Measurements were taken
with a microplate reader by using excitation and emis-
sion wavelengths of 490 and 525 nm, respectively. Per-
meability was calculated as previously described [19].
To measure transcellular permeability, 10 μL of 0.4 mg/mL
FITC-bovine serum albumin (FITC-BSA) (Invitrogen,
Waltham, MA, USA) was added to the upper chamber. The
remaining experimental procedure of transcellular permeabil-
ity detection is the same as that of paracelluar permeability.
Enzyme-linked immunosorbent assay
hMSCs co-cultured with HPMECs in different co-
culture conditions were stimulated by LPS. After 6 hours
of treatment, supernatants were collected and centri-
fuged to remove debris. HGF was determined via anenzyme-linked immunosorbent assay (ELISA) by using
commercially available ELISA sets (ExCell Biology, Inc.,
Shanghai, China). To remove the effect of cell numbers
on HGF secretion, we further tested HGF concentration
by ELISA quantification in conditioned medium from
six different formats: HPMEC alone, MSC alone, the
sum of HPMEC and MSC alone, the upper of MSC-EC
indirect co-culture, the lower of MSC-EC indirect co-
culture, and MSC-EC direct co-culture. In each format,
the number of cells seeded in the culture was held con-
stant at 1 × 105 and cultured for 1 to 3 days to allow the
growth of a confluent monolayer. Monolayers were
treated with 100 ng/mL LPS for 6 hours before examin-
ation. ELISA was performed in accordance with the in-
structions of the manufacturer. All samples were
measured in duplicate.
Immunofluorescence
In total, 5 × 104 HPMECs were seeded on the upper
chambers of 0.4-μm cell-culture inserts and cultured for
1 to 3 days to allow the growth of a confluent mono-
layer. Monolayers were treated with 100 ng/mL LPS be-
fore immunofluorescence. After 6-hour treatment, cells
Figure 2 Multilineage differentiation identification of human mesenchymal stem cells. Morphology of human mesenchymal stem cells at
the third passage (A) (100 T) and multilineage differentiation capacities of mouse mesenchymal stem cells, including adipogenic differentiation
stained with Oil Red O (B) (200 T), osteogenic differentiation stained with Alizarin red (C) (200 T), and chondrogenic differentiation stained with
Toluidine blue (D) (200 T), were observed by microscope.
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and fixed in 4% paraformaldehyde. Non-specific bind-
ing of antibody was blocked in 1% BSA in PBS for
30 minutes. Cells were stained with vascular endothelial
(VE)-cadherin antibody (Cell Signaling Technology,
Danvers, MA, USA) or F-actin antibody (Abcam, Hong
Kong) at 4°C overnight and then washed with PBS.
FITC-conjugated goat anti-mouse IgG (Jackson Immu-
noResearch Laboratories, Inc., West Grove, PA, USA)
was used as a secondary antibody. Finally, DAPI (4,6-
diamidino-2-phenylindole) was used to stain nuclei.
Samples were examined with a microscope (Olympus,
Tokyo, Japan) equipped with fluorescent illumination.
Western blot analysis
Total protein from cells was extracted by using RIPA
lysis buffer (Beyotime Institute of Biotechnology, Shanghai,
China) supplemented with 1 mmol/L phenylmethylsulfonyl
fluoride (PMSF), followed by separation by 6% or 12% so-
dium dodecyl sulphate-polyacrylamide gel electrophoresis
and transfer onto PVDF (polyvinylidene fluoride) mem-
branes (Well-Offer, Nanjing, China). Membranes were
then blocked in PBS-T containing 5% milk for 2 hours
at room temperature and incubated at 4°C overnight
with primary antibodies against VE-cadherin (Cell Signaling
Technology) or caveolin-1 (Epitomics, Burlingame, CA,USA). On the following day, blots were washed in PBS-T
and incubated in peroxidase-conjugated secondary anti-
body (HuaAn Biotechnology, Hangzhou, China) for 1 hour
at room temperature. Immunoreactive bands were obtained
by using a chemiluminescence imaging system (ChemiQ
4800mini; Ouxiang, Shanghai, China) after incubation with
horseradish peroxidase.
Human pulmonary microvascular endothelial cell
proliferation
To explore the role of HGF secreted by MSCs in
HPMEC proliferation, cell proliferation was analysed
by bromodeoxyuridine (BrdU) incorporation assay by
using a FITC-conjugated Brdu flow kit as described by
the manufacturer (KeyGEN bioTECH, Nanjing, China).
Briefly, HPMECs were seeded at 50,000 cells per insert
well and cultured for 1 to 3 days to allow the growth of a
confluent monolayer. MSCs co-cultured with HPMECs in
different co-culture conditions were stimulated by LPS.
Before termination of experiments, HPMECs were incu-
bated with 10 μM BrdU for 6 hours before analysis.
Statistical analysis
The results were presented as the mean ± standard devi-
ation. Statistical analyses were performed by using the
SPSS 16.0 software package (SPSS Inc., Chicago, IL,
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ance was used, followed by Tukey’s test. A P value less
than 0.05 was considered statistically significant.Results
Lipopolysaccharide evoked human pulmonary
microvascular endothelial cell hyperpermeability
LPS was used to induce endothelial injury and increase
endothelial permeability in our study. To find the
optimum dosage and time for LPS stimulation, we mea-
sured the paracellular permeability of HPMECs in re-
sponse to different LPS dosages at different time points
after LPS intervention. The results showed that the para-
cellular permeability had no significant alterations after
LPS addition with a dosage below 10 ng/mL. However,
the paracellular permeability significantly increased after
LPS stimulation with a dosage above 100 ng/mL in a
dose-dependent manner (P <0.01) (Figure 3A). Further-
more, we observed that the paracellular permeability sig-
nificantly increased after 6 hours following 100 ng/mL
LPS addition in a time-dependent manner (P <0.01)
(Figure 3B). Therefore, we studied HPMECs at 6-hour
exposure to 100 ng/mL LPS in subsequent experiments.Mesenchymal stem cell-endothelial cell interaction
restored the integrity of human pulmonary microvascular
endothelial cell monolayers
Microenvironment plays important roles in MSC bio-
logical function, through either direct or indirect contact
by paracrine-soluble factors from the neighbouring cells
[20]. To evaluate the effect of MSC-EC contact on
HPMEC permeability, we introduced two co-culture sys-
tems in our study and compared the paracellular andFigure 3 Lipopolysaccharide (LPS) evokes human pulmonary microvasc
of human pulmonary microvascular endothelial cells was measured at differe
results showed that paracellular permeability had no significant alterations aft
permeability significantly increased after LPS stimulation with dosages above
that paracellular permeability significantly increased after 6 hours following 10
mean ± standard error of three parallel experiments (n = 3, **P <0.01 versus gtranscellular permeability under these conditions. We
found that HPMEC paracellular permeability was signifi-
cantly decreased by both MSC-EC interaction and the
MSC group (P <0.01; Figure 4A). In addition, HPMEC
paracellular permeability was more significantly de-
creased by the MSC-EC interaction group than the MSC
group (P <0.05; Figure 4A). Similarly, HPMEC transcel-
lular permeability significantly decreased in both co-
culture systems (P <0.01; Figure 4B), while MSC-EC
interaction more significantly decreased HPMEC trans-
cellular permeability (P <0.05; Figure 4B).More hepatocyte growth factor was secreted under
mesenchymal stem cell-endothelial cell interactions
We measured the concentration of HGF in the culture
medium by using an ELISA kit. Interestingly, the results
indicated that the concentration of HGF in the MSC-EC
interaction group and the MSC group was significantly
higher than that of the LPS group. HGF levels in the
MSC-EC interaction group were much higher than that
of the MSC group (P <0.01; Figure 5C). These data sug-
gested that hMSCs might secrete more HGF by direct
culture with HPMECs than MSCs only directly cultured
with HPMECs. To remove the effect of cell numbers on
HGF secretion, we further tested HGF concentration by
ELISA quantification in conditioned medium from six
different formats: HPMEC alone, MSC alone, the sum
of HPMEC and MSC alone, the upper of MSC-EC indir-
ect co-culture, the lower of MSC-EC indirect co-
culture, and MSC-EC direct co-culture. The results
showed that the concentration of HGF in the MSC
group was significantly higher than that of the EC
group. HGF levels had no significant difference betweenular endothelial cell hyperpermeability. The paracellular permeability
nt LPS dosages and at different time points after LPS intervention. The
er LPS addition with dosages below 10 ng/mL. However, the paracellular
100 ng/mL in a dose-dependent manner (A). Furthermore, we observed
0 ng/mL LPS addition in a time-dependent manner (B). Shown are the
roup 0 ng/mL or 0 hours).
Figure 4 Mesenchymal stem cell-endothelial cell (MSC-EC) interaction promoted human MSCs to restore the integrity of human
pulmonary microvascular endothelial cell (HPMEC) monolayers. We found HPMEC paracellular permeability for both MSC-EC interaction and MSC
groups significantly decreased (P <0.01) (A). In addition, HPMEC paracellular permeability in the MSC-EC interaction group decreased more significantly than that
of the MSC group (P <0.05) (A). Similarly, HPMEC transcellular permeability significantly decreased in two co-culture systems (P <0.01) (B), while MSC-EC interaction
more significantly decreased HPMEC transcellular permeability (P <0.05) (B). (n=3, **p < 0.01 vs. group LPS; #p < 0.05 vs. group MSC). LPS, lipopolysaccharide.
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group, which were higher compared with the MSC group
and the sum of HPMEC and MSC-alone group (P <0.05
and P <0.01; Figure 5D). However, HGF levels in the
MSC-EC interaction group were highest in all six groups
(P <0.01; Figure 5D).Figure 5 More hepatocyte growth factor (HGF) was secreted under m
adopted two different co-culture conditions through transwell insert includ
concentration of HGF in the culture medium by using an enzyme-linked imm
of HGF in direct co-culture and indirect co-culture media was significantly hig
levels in direct co-culture medium were much higher than that of indirect co
indirect co-culture group). We further tested HGF concentration by ELISA qua
showed that the concentration of HGF in the MSC group was significantly hig
between the upper and lower of the MSC-EC indirect co-culture group, which
pulmonary microvascular endothelial cell (HPMEC) and MSC alone group (D) (P
were highest in all six groups (D) (P <0.01) (n = 3, *P <0.01 versus EC group, #P
$P <0.01 versus upper of MSC-EC indirect group or lower of MSC-EC indirect gHepatocyte growth factor neutralisation attenuated the
restoration of human pulmonary microvascular endothelial
cell monolayer integrity in mesenchymal stem
cell-endothelial cell interaction conditions
As HGF levels were upregulated in parallel to restore
the integrity of HPMEC monolayers in MSC-ECesenchymal stem cell-endothelial cell (MSC-EC) interactions. We
ing MSC-EC interactions (A) and MSCs (B). Then we measured the
unosorbent assay (ELISA) kit. The results indicated that the concentration
her than that of the lipopolysaccharide (LPS) group. Interestingly, HGF
-culture medium (C) (n = 3, **P <0.01 versus LPS group; ##P <0.01 versus
ntification in conditioned medium from six different formats. The results
her than that of the EC group. HGF levels had no significant difference
were higher compared with the MSC group and the sum of the human
<0.05 and P <0.01). However, HGF levels in the MSC-EC interaction group
<0.01 versus MSC group; &P <0.05, &&P <0.01 versus MSC + EC group,
roup). CM, conditioned media; hMSC, human mesenchymal stem cell.
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HGF in regulating the integrity of HPMEC monolayers.
hMSCs were co-cultured with direct contact to HPMECs
in the presence of 100 ng/mL anti-HGF antibody (Abcam)
for 24 hours. We found that the paracellular and transcel-
lular permeability in the anti-HGF antibody group was
significantly increased over the control (without anti-HGF
antibody) (n = 3, P <0.05) (Figure 6A, B), suggesting that
hMSCs restored the integrity of HPMEC monolayers in
MSC-EC interaction conditions by paracrine HGF.
Hepatocyte growth factor secreted in mesenchymal stem
cell-endothelial cell interaction conditions upregulated
endothelial vascular endothelial-cadherin protein and
decreased caveolin-1 protein expression
AJs represent the majority of junctions comprising the
endothelial paracellular barrier. AJs are composed of
VE-cadherin [21], whereas caveolin-1 is found in small
invaginations in the cell membrane and is thought to
play an important role in regulating the transcellular
permeability of HPMECs [22]. Therefore, in the present
study, to explore the mechanism of how HGF secreted
by MSCs improves endothelial barrier function, we ex-
amined endothelial VE-cadherin and caveolin-1 protein
expression under the co-culture conditions. Compared
with the MSC group, MSC-EC interaction increased VE-
cadherin protein expression (P <0.01; Figure 7A, C)
while reducing caveolin-1 protein expression in HPMECs
(P <0.01; Figure 7B, D). However, the MSC effect was
significantly blocked by anti-HGF antibody (P <0.05 or
P <0.01; Figure 7C, D). These results indicated that
HGF secreted by the MSC-EC interaction upregulatedFigure 6 Hepatocyte growth factor (HGF) neutralisation attenuated th
endothelial cell (HPMEC) monolayers in mesenchymal stem cell-endo
paracellular and transcellular permeability in the anti-HGF antibody (Ab) g
(n = 3, P <0.05) (A, B), suggesting that human MSCs restored the integrity
(n=3, **p < 0.01 vs. group LPS; #p<0.05 ##p < 0.01 vs. group MSC-EC interendothelial VE-cadherin protein and decreased caveolin-1
protein expression.
Hepatocyte growth factor secreted in mesenchymal stem
cell-endothelial cell interaction conditions restored
remodelling of endothelial F-actin and vascular
endothelial-cadherin
We further investigated the role and mechanism of
MSC-EC interaction in regulating remodelling of the
endothelial actin cytoskeleton and intercellular AJs by
immunofluorescence. The results indicated that HPMECs
cultured under normal conditions had F-actin localised
mainly at the cell periphery but that VE-cadherin, the
main component of AJs, formed intercellular junctions.
LPS induced dispersion of F-actin and VE-cadherin. After
3 to 5 days of MSC-EC interaction co-culture, remodelling
of F-actin and junctional localisation of VE-cadherin was
partially restored. However, neutralising HGF from the
conditioned media with anti-HGF antibody caused F-actin
(Figure 8) and VE-cadherin (Figure 9) to again be dis-
rupted. These data suggested that HGF secreted following
MSC-EC interaction restored remodelling of endothelial
F-actin and VE-cadherin.
Hepatocyte growth factor secreted by mesenchymal stem
cell-endothelial cell interaction induces proliferation in
human pulmonary microvascular endothelial cells
To explore the role of HGF secreted by MSCs in
HPMEC proliferation, cell proliferation was analysed by
BrdU incorporation assay as described in Xiong G et al.
[23]. The results indicated that MSCs induce proliferation
in HPMECs injured by LPS; interestingly, the proliferatione restoration of the integrity of human pulmonary microvascular
thelial cell (MSC-EC) interaction conditions. We found that the
roup was significantly increased over control (without anti-HGF Ab)
of HPMEC monolayers in MSC-EC interaction by paracrine HGF.
action) LPS, lipopolysaccharide.
Figure 7 Hepatocyte growth factor (HGF) secreted by human mesenchymal stem cells (hMSCs) following mesenchymal stem cell-endothelial
cell (MSC-EC) interactions upregulated vascular endothelial (VE)-cadherin protein and decreased caveolin-1 protein expression. Compared
with the MSC group, MSC-EC interaction increased VE-cadherin protein expression (P <0.01) (A, C) while reducing caveolin-1 protein expression in human
pulmonary microvascular endothelial cells (HPMECs) (P <0.01) (B, D). However, the MSC effect was significantly blocked by anti-HGF antibody (P <0.05 or
P <0.01) (C, D). These results indicated that HGF secreted by hMSCs upregulated endothelial VE-cadherin protein and decreased caveolin-1 protein
expression. (n=3, **p < 0.01 vs. group LPS, #p < 0.01 vs. MSC; &p< 0.05 &&p < 0.01 vs. group MSC-EC interaction) LPS, lipopolysaccharide.
Chen et al. Stem Cell Research & Therapy  (2015) 6:44 Page 8 of 12ratio in the MSC-EC interaction group was higher than
that of the MSC group (P <0.05; Figure 10); however, the
MSC-EC interaction effect was significantly blocked by
anti-HGF antibody (P <0.01; Figure 10), which explains
why there are more HPMECs in the MSC-EC group. The
result suggested that HGF secreted by MSC-EC inter-
action induces proliferation in HPMECs.
Discussion
ALI involves a disruption of the integrity of the endothe-
lial barrier, which causes pulmonary oedema with serum
proteins and oedema fluid. MSCs appear to restore
endothelial function, via both paracrine and cell contact-
dependent effects [17,24]. However, the detailed mech-
anism of how MSCs improve endothelial injury is still
unclear. In the present study, we found that MSC-EC
interaction promotes MSCs to restore the integrity of
EC monolayers induced by LPS via paracrine HGF,
which restore remodelling of endothelial intercellularAJs, decrease caveolin-1 protein expression, and induce
proliferation in HPMECs.
Pulmonary endothelium serves as a semi-selective barrier
between the plasma and interstitium to micromolecules and
bioactive agents. Endothelial injury results in barrier dys-
function, which contributes to pulmonary oedema in lung
injury [1]. There are two pathways regulating permeability
across the endothelial barrier: paracellular and transcellular
[25]. Paracellular permeability is determined primarily by
AJs and tight junctions. In contrast, the transcellular path-
way is defined as vesicle-mediated transport of macromole-
cules, such as albumin, across the endothelial barrier in a
caveolae-dependent manner [22]. Endotoxin, the bacterial
LPS, is considered an important factor in the development of
ALI, which increases the pulmonary endothelial paracellular
and transcellular permeability that causes pulmonary oedema
[3]. LPS has been widely adopted for in vivo and in vitro
studies of endothelial permeability injury mode [26-28].
In this study, we used an EC permeability injury model
Figure 8 Hepatocyte growth factor (HGF) secreted in mesenchymal stem cell-endothelial cell (MSC-EC) interactions conditions restored
remodelling of endothelial F-actin. The results indicated that human pulmonary microvascular endothelial cells cultured under normal condition
had F-actin localised mainly at the cell periphery. Lipopolysaccharide (LPS) induced dispersion of F-actin. After 7 days of direct or indirect co-culture
with human MSCs, remodelling of F-actin was partially restored. However, neutralising HGF from conditioned media with anti-HGF antibody caused
F-actin to be disrupted again. DAPI, 4,6-diamidino-2-phenylindole.
Chen et al. Stem Cell Research & Therapy  (2015) 6:44 Page 9 of 12induced by LPS, which caused an increase in EC para-
cellular permeability in a time- and dose-dependent man-
ner. Our study showed that the paracellular permeability
significantly increased after 6 hours following 100 ng/mL
LPS addition, in accordance with the previous study [29].
Therefore, we studied HPMECs at 6-hour exposure to
100 ng/mL LPS in subsequent experiments.Figure 9 Hepatocyte growth factor (HGF) was secreted in mesenchym
restored remodelling of vascular endothelial (VE)-cadherin. The results
cultured under normal conditions had VE-cadherin, the main component of a
(LPS) induced dispersion of VE-cadherin. After 7 days of direct or indirect co-c
neutralising HGF from conditioned media with anti-HGF antibody (Ab) causedMSCs have potent stabilising effects on vascular endo-
thelium injury by inhibiting endothelial permeability. A
strong paracrine capacity has been proposed as the prin-
cipal mechanism [7]. MSCs are capable of secreting a
few factors under normal conditions. Thus, some studies
make an effort to maximise the paracrine potential of
MSCs. For instance, hypoxic preconditioning of MSCsal stem cell-endothelial cell (MSC-EC) interaction conditions and
indicated that human pulmonary microvascular endothelial cells
dherens junctions, forming intercellular junctions. Lipopolysaccharide
ultured with human MSCs, VE-cadherin was partially restored. However,
VE-cadherin to be disrupted again. DAPI, 4,6-diamidino-2-phenylindole.
Figure 10 Hepatocyte growth factor (HGF) secreted by mesenchymal stem cell-endothelial cell (MSC-EC) interaction induces proliferation
in human pulmonary microvascular endothelial cells (HPMECs). To explicit effect of HGF secreted by MSCs on HPMEC proliferation, cell
proliferation was analysed by bromodeoxyuridine (BrdU) incorporation assay. The results indicated that MSCs induce proliferation in HPMECs injured
by lipopolysaccharide (LPS). Interestingly, the proliferation ratio in the MSC-EC interaction group was higher than that of the MSC group (P <0.05).
However, the MSC-EC interaction effect was significantly blocked by anti-HGF antibody (P <0.01), which explains why there are more HPMECs in the
MSC-EC group. The result suggested that HGF secreted by MSC-EC interaction induces proliferation in HPMECs (n = 3, *P <0.01 versus control group,
#P <0.01 versus LPS group; &P <0.05 versus MSC group, $P <0.01 versus MSC-EC interaction).
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Pati S et al. showed that conditioned medium from
MSC-EC co-cultures, but not from ECs or MSCs cul-
tured alone, can decrease endothelial permeability [18],
suggesting that MSCs can exert a better effect through
the secretion of soluble factors induced by contact with
ECs [30,31]. To clarify the role of paracrine interactions
between ECs and MSCs, we adopted an MSC-EC inter-
action co-culture system in our study. Our data demon-
strated that MSC-EC interaction restores the integrity of
HPMEC monolayers. These findings suggest that MSCs in
contact with ECs can exert a beneficial effect, possibly
through the increased secretion of a soluble factor.
HGF is a multifunctional, mesenchyme-derived pleio-
tropic factor secreted by several cell types [32-34] and regu-
lates many biological events, such as cell mitogenesis,
organogenesis, morphogenesis, and cell survival [35,36].
Novel therapeutic strategies using HGF to fight lung dis-
eases have been suggested because HGF exhibited sus-
tained barrier-protective effects on ECs [34]. Recently, it
has been suggested that HGF appears in lung circulation
under ALI, exhibiting sustained barrier-protective effects
on human pulmonary ECs [34]. HGF resulting from MSC-
EC interaction may be responsible for improving HPMEC
permeability. Our results indicated that MSCs or HPMECsalone secrete little HGF but that MSCs in contact with ECs
secrete more HGF in parallel with restoring the integrity of
HPMEC monolayers. However, the effect of MSCs was sig-
nificantly blocked following HGF neutralisation with anti-
HGF antibody. Thus, HGF, a soluble factor secreted by
hMSCs, may account for the effect that restored the integ-
rity of EC monolayers in direct co-culture conditions.
HGF-induced endothelial permeability effects on ECs
have been associated with remodelling of the actin cyto-
skeleton as well as the increased expression of the AJ
protein VE-cadherin. Endothelial paracellular permeabil-
ity is determined primarily by AJs and tight junctions
[21]. ECs express high levels of VE-cadherin, which in-
teracts on neighbouring ECs to form AJs. AJs represent
the majority of junctions comprising the endothelial
paracellular barrier. AJs are composed of VE-cadherin
[37]. Our results showed that LPS stimulation caused
dispersion of VE-cadherin but that MSC-EC interaction
increased VE-cadherin protein expression and restored
remodelling of endothelial F-actin, which restored the
integrity of EC monolayers. However, the MSC effect
was significantly blocked by anti-HGF antibody. Thus,
HGF secreted by MSCs following MSC-EC interaction
restored paracellular permeability by remodelling of
endothelial F-actin and VE-cadherin.
Chen et al. Stem Cell Research & Therapy  (2015) 6:44 Page 11 of 12Caveolin-1 is thought to play an important role in
regulating endothelial transcellular permeability [19,38].
The transcellular pathway is defined as vesicle-mediated
transport of macromolecules, such as albumin, across
the endothelial barrier in a caveolae-dependent manner.
Caveolin-1 regulates endothelial transcellular transport
of macromolecules [22] that, in turn, is concomitant
with the onset of the increase of transcellular permeabil-
ity. LPS was shown to induce the expression of caveolin-
1 in ECs and thereby contribute to the mechanism of
increased transcellular permeability [39,40]. Similarly,
our data showed that MSCs co-cultured in contact with
ECs more significantly decreased caveolin-1 protein ex-
pression in ECs. However, the effect of MSCs was sig-
nificantly blocked by anti-HGF antibody. These results
indicated that HGF secreted by MSCs following MSC-
EC interaction restores transcellular permeability by re-
ducing caveolin-1 protein expression.
A limitation of our study should be noted. Our study
suggested that HGF secreted by hMSCs following MSC-
EC interaction may account for the effect that restored
the integrity of EC monolayers. However, ECs can also
secrete a small amount of HGF induced by LPS. Thus, a
small amount of HGF secreted following MSC-EC inter-
action comes from ECs. To solve this problem, the iden-
tification of HGF protein expression in MSCs may be
helpful. However, it is very difficult to separate MSCs
from ECs after MSC-EC contact during co-culture. Our
future studies will employ techniques such as magnetic
cell sorting to separate MSCs from ECs.
Conclusions
In summary, here we have shown that MSC-EC inter-
action decreased endothelial paracellular and transcellu-
lar permeability induced by LPS. HGF secreted by
hMSCs may account for the effect that restored the in-
tegrity of EC monolayers. The main mechanisms by
which HGF restored paracellular permeability are re-
modelling of endothelial intercellular AJs, decreasing
caveolin-1 protein expression, and inducing proliferation
in HPMECs.
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